Stay updated on RP-A601 in PKP2-ACM Clinical Trial
Sign up to get notified when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.

Latest updates to the RP-A601 in PKP2-ACM Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section listing California, North Carolina, and Pennsylvania, and removed the separate state location blocks; the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.2 was introduced; no changes to the study details, eligibility criteria, locations, or contacts are visible; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page shows an updated revision number (from v3.2.0 to v3.3.1). The study details and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedNotice about government funding lapse and potential delays in updates to NIH/ClinicalTrials.gov information was removed from the page. This removes a warning regarding the currency of data on the study record.SummaryDifference0.4%

- Check55 days agoChange DetectedNo significant changes detected on the Study Details page; the content and layout appear unchanged, with no new or removed critical study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference6%

Stay in the know with updates to RP-A601 in PKP2-ACM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.